Mahindra & Mahindra Q3 Results 2024
- Published Date: February 19, 2024
- Updated Date: June 17, 2025
- By Team Choice
Mahindra & Mahindra Quarterly result 2023-24
| Result snapshot (Rs. mn.) | Q3FY24 | Q3FY23 | YoY (%) | Q2FY24 | QoQ (%) | CEBPL EST. | Dev.(%) |
|---|---|---|---|---|---|---|---|
| Net sales (incl 001) | 252,885 | 216,537 | 16.8 | 243,099 | 4.0 | 2,54,468 | -0.6 |
| Material Exp. | 190,660 | 164,471 | 15.9 | 183,793 | 3.7 | 192,378 | |
| Employee Exp. | 11,343 | 9,342 | 21.4 | 11,262 | 0.7 | 11,451 | |
| Other Operating Exp. | 18,518 | 14,583 | 27.0 | 18,703 | (1.0) | 20,103 | |
| EBITDA | 32,364 | 28,142 | 15.0 | 29,341 | 10.3 | 30,536 | 6.0 |
| Depreciation | 8,179 | 8,292 | -1.4 | 8,158 | 0.3 | 8,400 | |
| Other Income | 7,370 | 6,700 | 10.0 | 22,819 | (67.7) | 6,999 | |
| EBIT | 24,186 | 19,851 | 21.8 | 21,182 | 14.2 | 22,136 | |
| Interest Cost | 348 | 686 | -49.2 | 329 | 5.7 | 600 | |
| Exceptional Item | - | (6,289) | NA | - | NA | - | |
| PBT | 31,207 | 19,576 | 59.4 | 43,672 | (28.5) | 28,535 | |
| RPAT | 22,054 | 13,182 | 67.3 | 37,964 | (41.9) | 19,382 | 13.8 |
| APAT | 22,054 | 17,899 | 23.2 | 37,964 | (41.9) | 19,382 | |
| Adj. EPS | 18 | 14 | 23.2 | 31 | (41.9) | 16 | 13.8 |
| Operational Performance | Q3FY24 | Q3FY23 | YoY (bps) | Q2FY24 | QoQ (bps) | CEBPL EST. Dev. (bps) | Dev.(%) |
|---|---|---|---|---|---|---|---|
| Gross margin (%) | 24.6 | 24.0 | 56 | 24.4 | 21 | 24.4 | |
| EBITDA margin (%) | 12.8 | 13.0 | (20) | 12.1 | 73 | 12.0 | 79.8 |
| Employee Exp. (% of Sales) | 4.5 | 4.3 | 17 | 4.6 | (15) | 4.5 | |
| Other Operating Exp. (% of Sales) | 7.3 | 6.7 | 59 | 7.7 | (37) | 7.9 | |
| RPAT margin (%) | 8.7 | 6.1 | 263 | 15.6 | (690) | 7.6 | 110.4 |
Source: Company, CEBPL
Recommended for you
FII DII Data - Live Data
10 Best SIP Plans For ₹1000 Per Month in 2025
Pharma Mutual Funds – Best Option to Invest in 2025?
Invest in best pharma mutual funds in India for 2020 with Investica. Explore our top recommended pharma mutual funds to start investing today.
